Announcements

Maze Therapeutics, Inc. (NASDAQ: MAZE) reported that Bernstein Harold exercised options covering 36,141 shares in two transactions on 1 September 2026. The exercises were priced from $0 to $10.42 per share, and the filing reports that the sale left Bernstein Harold with zero shares.

Maze Therapeutics, Inc. (NASDAQ: MAZE) saw CSBO Dandekar Atul exercise options for 12,500 shares at $0 on Sep. 1, 2026. The transaction left Dandekar Atul with 38,750 shares, according to the post-transaction ownership record.

Dianthus Therapeutics, Inc. /DE/ (NASDAQ: DNTH) executive vice president and head ofResearch and DevelopmentRandhawa Simrat exercised options covering 23,124 shares in three transactions on 1 September 2026. The exercise prices ranged from $17.88 to $22.07 per share.

eHealth awarded Galimi Gavin G., its SVP, General Counsel & Secr., 60,000 shares at $0 per share on 2026-09-01. The award leaves the executive with 335,035 eHealth shares, giving investors the disclosed post-transaction ownership figure tied to the senior legal officer’sEquityposition.Key HighlightsThe award was …

Entrada Therapeutics, Inc. (NASDAQ: TRDA) saw Chief Financial Officer Wentworth Kory James forfeit 1,733 shares at $7.14 per share. The transaction left James with 117,277 shares.

Doshi Dipal forfeited 8,724 shares of Entrada Therapeutics on September 2, 2026, in an insider transaction. The transaction was followed by a reported ownership balance of 517,290 shares for Dipal.

GE HealthCare Technologies Inc. (NASDAQ: GEHC) reported that Rackliffe Philip, its CEO, AIS, forfeited 856 shares at $71.23 per share. After the transactions, Philip’s ownership stood at 42,331 shares. The action took place on 1 September 2026. The 856-share total was spread across three …